Classical Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Classical Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy [Phase 2]
A Phase 2 clinical trial update for OPTmizing Advanced Stage Hodgkin Lymphoma Therapy is listed, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-04-24Clinical Trial Update: Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating Brentuximab Vedotin as pre-transplant induction and consolidation in relapsed or refractory classical Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating lenalidomide in relapsed or refractory classical Hodgkin lymphoma has completed. Results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma [Phase 2]
Phase 2 study update for Rituximab-ABVD in classical Hodgkin lymphoma has completed recruitment with results posted in 2015.